Rational approaches to treatment duration with immunotherapy for kidney cancer
A recent review of the use of immune checkpoint inhibitors [...]
Individualised treatment plans improve outcomes for kidney cancer
Over the past couple of years there have been several [...]
ESMO 2019: Results from TITAN-RCC tailored immunotherapy clinical trial
Results from the TITAN-RCC clinical trial to assess tailored immunotherapy [...]
